Pulmonx Gross Profit 2019-2025 | LUNG
|
Pulmonx Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $62 |
| 2023 | $51 |
| 2022 | $40 |
| 2021 | $36 |
| 2020 | $21 |
| 2019 | $22 |
| 2018 | $12 |
|
Pulmonx Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $16 |
| 2025-06-30 | $17 |
| 2025-03-31 | $16 |
| 2024-12-31 | $18 |
| 2024-09-30 | $15 |
| 2024-06-30 | $15 |
| 2024-03-31 | $14 |
| 2023-12-31 | $14 |
| 2023-09-30 | $13 |
| 2023-06-30 | $13 |
| 2023-03-31 | $11 |
| 2022-12-31 | $11 |
| 2022-09-30 | $10 |
| 2022-06-30 | $10 |
| 2022-03-31 | $8 |
| 2021-12-31 | $10 |
| 2021-09-30 | $10 |
| 2021-06-30 | $9 |
| 2021-03-31 | $7 |
| 2020-12-31 | $7 |
| 2020-09-30 | $7 |
| 2020-06-30 | $1 |
| 2020-03-31 | $6 |
| 2019-12-31 | |
| 2019-09-30 | $6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.061B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $11.897B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $1.978B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |